[go: up one dir, main page]

DK2379066T3 - Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme - Google Patents

Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme

Info

Publication number
DK2379066T3
DK2379066T3 DK08807092.5T DK08807092T DK2379066T3 DK 2379066 T3 DK2379066 T3 DK 2379066T3 DK 08807092 T DK08807092 T DK 08807092T DK 2379066 T3 DK2379066 T3 DK 2379066T3
Authority
DK
Denmark
Prior art keywords
degenery
diseases
retained
medicine
preparation
Prior art date
Application number
DK08807092.5T
Other languages
English (en)
Inventor
Ibrahim Mustafa Iskender Pisak
Mehmet Levent Selamoglu
Nevhiz Pak
Semra Bingol
Original Assignee
Imunek Farma Ilaç Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imunek Farma Ilaç Sanayi Ve Ticaret A S filed Critical Imunek Farma Ilaç Sanayi Ve Ticaret A S
Application granted granted Critical
Publication of DK2379066T3 publication Critical patent/DK2379066T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08807092.5T 2008-09-16 2008-09-16 Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme DK2379066T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/002412 WO2010032073A1 (en) 2008-09-16 2008-09-16 Use of opioid antagonists for the preparation of a medicament in the treatment of retinal degenerative diseases

Publications (1)

Publication Number Publication Date
DK2379066T3 true DK2379066T3 (da) 2014-06-30

Family

ID=41138810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08807092.5T DK2379066T3 (da) 2008-09-16 2008-09-16 Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme

Country Status (10)

Country Link
US (1) US20110165232A1 (da)
EP (1) EP2379066B1 (da)
CY (1) CY1115269T1 (da)
DK (1) DK2379066T3 (da)
ES (1) ES2475199T3 (da)
HR (1) HRP20140596T1 (da)
PL (1) PL2379066T3 (da)
PT (1) PT2379066E (da)
SI (1) SI2379066T1 (da)
WO (1) WO2010032073A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201203732T1 (tr) * 2009-10-01 2012-09-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
TR201002473A2 (tr) 2010-03-31 2011-09-21 Mustafa Nevzat �La� Sanay�� A.�. Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi.
US9993433B2 (en) 2010-05-10 2018-06-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
ES2408343B2 (es) 2010-05-10 2014-07-17 Euro-Celtique, Sa Composiciones farmacéuticas que comprenden hidromorfona y naloxona
MX344846B (es) 2010-05-10 2017-01-10 Euro-Celtique S A * Combinacion de granulos cargados activos con activos adicionales.
US20140213605A1 (en) * 2013-01-27 2014-07-31 Remedeye Inc. Methods for treating eye disorders using opioid receptor antagonists
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416886A (en) * 1981-07-29 1983-11-22 Dermall Limited Method of treating pruritis and composition therefor
US5356900A (en) * 1986-10-07 1994-10-18 Bernard Bihari Method of treating chronic herpes virus infections using an opiate receptor antagonist
US4888346A (en) * 1986-10-07 1989-12-19 Bernard Bihari Method for the treatment of persons infected with HTLV-III (AIDS) virus
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
DE4222534A1 (de) * 1992-07-09 1994-01-13 Behringwerke Ag Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
US6074642A (en) * 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US6384044B1 (en) 1999-11-29 2002-05-07 Bernard Bihari Method of treating cancer of the prostate
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US20030072724A1 (en) * 1999-12-16 2003-04-17 Maibach Howard I. Topical pharmaceutical composition to treat hyperpigmentation of the skin
WO2001057184A2 (en) 2000-02-01 2001-08-09 Vanderbilt University Use of platelet activity modulators for inhibiting complement activation
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
US20030235542A1 (en) * 2002-06-21 2003-12-25 Maibach Howard I. Topical administration of pharmacologically active bases for skin lightening
US6821523B2 (en) * 2002-06-21 2004-11-23 Dermatrends, Inc. Topical administration of pharmacologically active bases in the treatment of warts
AU2004229551A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
JP4343948B2 (ja) * 2003-04-29 2009-10-14 オレキシジェン・セラピューティクス・インコーポレーテッド 体重減少に影響を及ぼすための組成物
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
JP2006131545A (ja) * 2004-11-05 2006-05-25 Japan Science & Technology Agency 神経因性疼痛治療剤
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8916195B2 (en) * 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US8829020B2 (en) * 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
TR201203732T1 (tr) * 2009-10-01 2012-09-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
TR201002473A2 (tr) * 2010-03-31 2011-09-21 Mustafa Nevzat �La� Sanay�� A.�. Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi.

Also Published As

Publication number Publication date
EP2379066A1 (en) 2011-10-26
HRP20140596T1 (hr) 2014-08-01
US20110165232A1 (en) 2011-07-07
PL2379066T3 (pl) 2014-09-30
PT2379066E (pt) 2014-07-04
WO2010032073A1 (en) 2010-03-25
EP2379066B1 (en) 2014-03-26
CY1115269T1 (el) 2017-01-04
SI2379066T1 (sl) 2014-08-29
ES2475199T3 (es) 2014-07-10

Similar Documents

Publication Publication Date Title
PL2257305T3 (pl) Nowy farmaceutyczny preparat do leczenia stanu przedrzucawkowego
DK2073860T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
BRPI0906467A2 (pt) forma de dose farmacêutica
DK2173407T3 (da) Anordning til indgivelse af lægemiddel
EP2132133A4 (en) RELEASE OF PARTICULATE ACTIVE SUBSTANCES
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
BRPI0920514A2 (pt) infusão de fármacos
DK2222272T3 (da) Behandling af luftvejssygdom
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DE602007000323D1 (de) Abgabe von therapeutischen Vorrichtungen
DK2399579T3 (da) Farmaceutiske doseringsformer
CY2016053I2 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
DK2381988T3 (da) Medikamentadministrationsanordning
SI2582366T1 (sl) Farmacevtska kombinacija za zdravljenje bolečine
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2506712T3 (da) Morfinanderivater til behandling af lægemiddeloverdosering
DK3005986T3 (da) Infusion af lægemidler
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
PL2379086T3 (pl) Preparat farmeceutyczny
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2379066T3 (da) Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme
DK2271618T3 (da) Farmaceutiske forbindelser
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme